Who is sponsoring NCT01865916?

NCT01865916 is sponsored by University of British Columbia.

What drugs are being tested in NCT01865916?

Interventions in NCT01865916: Polyethylene Glycol (PEG) and 15 mg Bisacodyl, Polyethylene Glycol (PEG) + ascorbic acid.

What condition does NCT01865916 study?

NCT01865916 studies Colonoscopy.

Is NCT01865916 still recruiting?

NCT01865916 is currently completed. Last updated 16 June 2016.

Last reviewed 2016-06-16 · How we verify

NCT01865916

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation: A Randomized, Non-Inferiority Open Trial

Completed Phase 4 Last updated 16 June 2016

What this trial tests

Phase 4 trial testing Polyethylene Glycol (PEG) and 15 mg Bisacodyl in Colonoscopy in 309 participants. Completed in 1 February 2016.

Timeline

1 April 2013

Primary endpoint
1 December 2015

1 February 2016

Quick facts

Lead sponsor	University of British Columbia
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Enrollment	309
Start date	1 April 2013
Primary completion	1 December 2015
Estimated completion	1 February 2016
Sites	1 location across Canada

Drugs / interventions tested

Polyethylene Glycol (PEG) and 15 mg Bisacodyl — full drug profile →
Polyethylene Glycol (PEG) + ascorbic acid — full drug profile →

Conditions studied

Colonoscopy — all drugs for Colonoscopy →

Sponsor

University of British Columbia

Who can join

19 and older, any sex, with Colonoscopy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Bowel cleansing efficacy as rated by a Boston Bowel Preparation Scale score of greater than 8
Time frame: 20 hours
The BBPS is a relatively new, validated scoring system assessing cleanliness of three segments of the colon (left colon, transverse, and right colon). The total is a 10 point scale (0-9) that grades each segment of the colon from 0-3. A segment score of 0 describes: 'unprepared colon segment with mucosa not well seen due to solid stool that cannot be cleared'. Segment score 1: 'portion of mucosa o

Sponsor's own description

This study is a randomized, controlled, single centre, endoscopist-blinded non-inferiority trial. The purpose of our study is to determine if using a 2-litre mixture in combination with vitamin C is better than using 2 litres of mixture with bisacodyl tablets. Two-litre PegLyte based preparations with an added laxative agent are commonly used for colonoscopies in outpatient settings. If the investigators discover that a 2-litre mixture with either the tablets or the ascorbic acid work better, future patients undergoing colonoscopy will be able to experience fewer side effects and be less troubled by the preparation while still allowing a good view of the colon.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Colonoscopy

Currently open trials in the same condition.

NCT07353853 — Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease · NA · recruiting
NCT07335705 — Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients · recruiting
NCT06763705 — Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy · Phase 4 · recruiting
NCT07171853 — The Carbon Footprint Study of Colonoscopy · recruiting
NCT07355777 — Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation · NA · recruiting

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01865916 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 16 June 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01865916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing